大动脉狭窄中的左心室缩:早期细胞和矩阵回归2个月大动脉置换后的左心室缩
Jonathan Bennett1,2, George D Thornton1,2, Christian Nitsche1,2,3
1Institute of Cardiovascular Science, University College London, United Kingdom (J.B., G.D.T., C.N., N.A., R.H.D., J.C.M., T.A.T.).
Circulation. Cardiovascular imaging
|December 4, 2024
概括
大动脉置换 (AVR) 后,左心室缩迅速回归,细胞组成部分比细胞外组成部分缩小更多. 这种早期的心肌适应减轻后负荷,揭示了对AVR后心脏重塑的洞察力.
科学领域:
- 心血管医学 心血管医学
- 心脏成像 - - 心脏成像
- 肌肉心脏重塑 肌肉心脏重塑
背景情况:
- 大动脉狭窄导致左心室缩 (LVH) 由于细胞和细胞外矩阵扩张.
- 大动脉置换 (AVR) 后发生左心室缩回归,但早期的细胞和细胞外动态仍然不清楚.
研究的目的:
- 在AVR后的左心室缩回归期间调查早期细胞和细胞外心肌动力学.
- 评估AVR对左心室质量,应变和细胞外体积分数的影响.
主要方法:
- 预期招募患有严重症状性大动脉狭窄症的患者进行AVR.
- 心脏磁共振成像 (MRI) 在AVR前和早期AVR后进行,以评估LV重塑,全球纵向应变,并为细胞外体积分数绘制T1映射.
主要成果:
- 在AVR后显著减少了LV质量指数 (15.4%),这是由于细胞 (18.7%) 比细胞外 (7.2%) 的回归更大.
- 由于不平衡的回归,细胞外体积分数明显增加 (27.4%至30.2%).
- 全球纵向应变没有显著变化,但细胞外体积分数增加与应变恶化相关.
结论:
- 在AVR后的早期LVH回归涉及细胞和细胞外,展示了心肌适应性.
- 细胞回归比细胞外回归更大,导致细胞外体积分增加.
- 透导管和外科AVR都有效地促进有益的反向重塑.
相关概念视频
Mitral Stenosis I: Introduction
Mitral Valve Stenosis (MVS) is a heart condition where the mitral valve narrows, impeding blood circulation from the left atrium to the left ventricle. The etiology and pathophysiology of this condition are multifaceted, leading to a cascade of cardiovascular complications.Causes of Mitral Valve StenosisRheumatic Heart Disease: It is the main cause of mitral valve stenosis, particularly in developing nations. This condition arises from rheumatic fever, an inflammatory illness resulting from...
Mitral Stenosis II: Clinical features and Diagnostic Tests
Mitral stenosis is a heart condition in which the mitral valve, which allows blood to flow from the left atrium to the left ventricle, becomes narrowed or stenotic. This narrowing hinders blood flow and leads to clinical symptoms requiring specific medical evaluations and management strategies. The following overview outlines the clinical symptoms, assessments, diagnostic findings, prevention methods, and treatments for mitral stenosis.Clinical ManifestationsDyspnea (shortness of breath): This...
Aortic Regurgitation I: Introduction
IntroductionAortic regurgitation is characterized by the backward flow of blood from the aorta into the left ventricle during diastole and arises from the improper closure of the aortic valve. This condition results in left ventricular volume overload and can stem from both acute and chronic etiologies, each contributing uniquely to the disease's progression and symptomatology.Acute and Chronic CausesAcute aortic regurgitation often results from events that suddenly impair the integrity of the...
Aortic Regurgitation II: Clinical Features and Diagnostic Tests
Aortic valve regurgitation (AR) occurs when the aortic valve fails to close properly, allowing blood to flow backward from the aorta into the left ventricle. This backflow can result in two distinct clinical presentations: acute and chronic AR, each characterized by its own set of symptoms and physical findings.Acute Aortic RegurgitationAcute AR presents with a sudden onset of severe symptoms. Patients typically experience profound dyspnea (shortness of breath), chest pain, and signs of left...
Aortic Regurgitation III: Medical Management
Aortic regurgitation (AR) is when the aortic valve does not close or seal properly, leading to backward blood circulation from the aorta into the left ventricle during diastole. Common causes of AR include rheumatic heart disease, congenital valve defects, and aortic root dilation. Managing AR requires a multifaceted approach to alleviate symptoms, preserve left ventricular function, and address the underlying cause of the regurgitation. Patients with symptomatic AR or significant left...
Heart Failure II: Pathophysiology
Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...


